Medscape Internal Medicine Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Maternal Obesity Associated With Higher Risk for Stillbirth Maternal Obesity Associated With Higher Risk for Stillbirth
Findings from a large cohort study suggested that early delivery could reduce the risk for stillbirth in patients with obesity.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 11, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology Source Type: news

COVID Virus Can Remain in the Body Over a Year COVID Virus Can Remain in the Body Over a Year
Scientists found COVID antigens in the blood for up to 14 months after infection and in tissue samples for more than 2 years after infection.WebMD Health News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 11, 2024 Category: Internal Medicine Tags: Infectious Diseases Source Type: news

New NCCN Melanoma Guidelines Capture Evolving Best Practice New NCCN Melanoma Guidelines Capture Evolving Best Practice
NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 9, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news

FDA Approves Second Tocilizumab Biosimilar FDA Approves Second Tocilizumab Biosimilar
Tocilizumab-aazg (Tyenne) is approved in both intravenous and subcutaneous formulations.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 7, 2024 Category: Internal Medicine Tags: Rheumatology Source Type: news

Artificially Sweetened Drinks Linked to Increased AF Risk Artificially Sweetened Drinks Linked to Increased AF Risk
Drinking 2 L or more of artificially sweetened drinks per week was associated with a 20% increased risk for atrial fibrillation in a new observational study.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 6, 2024 Category: Internal Medicine Tags: Cardiology Source Type: news

A New Biomarker of Brain Injury? A New Biomarker of Brain Injury?
Iron accumulation in the brain may be a biomarker of concussion and posttraumatic headache, new research suggests.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 5, 2024 Category: Internal Medicine Tags: Neurology & Neurosurgery Source Type: news

WHO Warns Of Growing Resistance to GSK's HIV Drug WHO Warns Of Growing Resistance to GSK's HIV Drug
The World Health Organization (WHO) said on Tuesday resistance to GSK ' s HIV drug dolutegravir has exceeded levels observed during its trials, citing observational and survey...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 5, 2024 Category: Internal Medicine Tags: HIV/AIDS Source Type: news

Patient-Reported Outcomes Important in Cutaneous GVHD: Study Patient-Reported Outcomes Important in Cutaneous GVHD: Study
The study results " highlight the importance of patient-reported outcomes in measuring this disease, " the study ' s lead author said.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 4, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news

What ’s The Incidence Rate of a Second Primary Melanoma? What ’s The Incidence Rate of a Second Primary Melanoma?
The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 29, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news

FDA OKs 10th Humira Biosimilar, Interchangeability Included FDA OKs 10th Humira Biosimilar, Interchangeability Included
It is the tenth adalimumab biosimilar approved by the regulatory agency.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 26, 2024 Category: Internal Medicine Tags: Rheumatology Source Type: news

HPV and Tobacco: Dangerous Lesions HPV and Tobacco: Dangerous Lesions
Smoking increases the risk for HPV infection by impairing immunity and reducing antibody titers, according to a gynecologist.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 23, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news

Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry ' s embrace of expensive therapies for rare...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 23, 2024 Category: Internal Medicine Tags: Family Medicine/Primary Care Source Type: news

Will More Red Light at Home Keep Blood Glucose in Check? Will More Red Light at Home Keep Blood Glucose in Check?
Researchers have found that shining 670 nm-length red light on healthy people reduces postconsumption elevation of blood glucose levels.Medscape News UK (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 22, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology Source Type: news

Intellectual Disabilities Linked With Worse Cancer Survival Intellectual Disabilities Linked With Worse Cancer Survival
People with intellectual or developmental disabilities may be 2.57 times more likely to die of colorectal cancer than those without these disabilities.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 22, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news

Bi-weekly Dose Of Johnson & Johnson's Blood Cancer Therapy Gets US FDA Approval Bi-weekly Dose Of Johnson & Johnson's Blood Cancer Therapy Gets US FDA Approval
The U.S. Food and Drug Administration has approved a bi-weekly dose of Johnson& Johnson ' s blood cancer therapy Tecvayli, the drugmaker said on Tuesday.Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 20, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news